. Nanosight (NTA) Characterization of serum-derived EVs from TBI patients with and without lung injury. NTA analysis showing significant difference in particle concentration (per mL of PBS) between serum-derived EVs from TBI patients with lung injury (n = 13) and TBI patients with no lung injury (n = 8, ** p < 0.05).
Supplemental Figure 2. Figure S2. EV depleted isolations do not activate the inflammasome in pulmonary endothelial cells. (A,B)
Representative Nanosight analysis shows a 6.9 fold decrease in EVs from 8.49 × 10 9 (EVs) to 1.25 × 10 9 particles/mL (EV depleted) particles/mL from depleted samples. (C,D) Representative Western blots (C) and quantification (D) show that HMVEC-L treated with EV depleted samples have a significantly lower expression of caspase-1, and CD81 after delivery to HMVEC-L (n = 3, * p < 0.05).
